Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Retatrutide Reddit: What Real Users Report in 2026
articleA research-phase synthesis of what Reddit communities actually report about retatrutide: first-week appetite suppression, dysesthesia, the switcher question from tirzepatide, post-trial maintenance, and where community claims align with the clinical data.
Semaglutide Reddit: What the Community Gets Right and Wrong
articleMost semaglutide Reddit roundups just repeat what the community believes. This one checks each recurring claim against the FDA label and the peer-reviewed literature, then labels it corroborated, contradicted, or anecdote only.
Tirzepatide Reddit: What Real Users Report in 2026
articleA synthesis of what tirzepatide Reddit communities actually report in aggregate: weight-loss patterns, the side effects that come up most, the compounded-versus-brand debate, and where community talking points line up with the clinical evidence.
Microdosing GLP-1 Reddit: What the Community Actually Reports
articleA community synthesis of what Reddit threads actually report about GLP-1 microdosing: fewer side effects, the "just 10 lbs" cohort, off-label inflammation use, and where anecdote meets pharmacokinetics. Anecdotes, not medical advice.